Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 22 studies | 23% ± 8% | |
type I pneumocyte | 12 studies | 35% ± 16% | |
basal cell | 11 studies | 31% ± 16% | |
capillary endothelial cell | 8 studies | 21% ± 4% | |
smooth muscle cell | 6 studies | 20% ± 3% | |
ciliated cell | 6 studies | 25% ± 7% | |
epithelial cell | 5 studies | 36% ± 14% | |
endothelial cell of artery | 5 studies | 19% ± 3% | |
vein endothelial cell | 5 studies | 26% ± 15% | |
secretory cell | 4 studies | 26% ± 4% | |
mesothelial cell | 4 studies | 30% ± 14% | |
pericyte | 4 studies | 21% ± 2% | |
club cell | 4 studies | 24% ± 4% | |
glomerular endothelial cell | 3 studies | 19% ± 1% | |
endothelial cell of vascular tree | 3 studies | 25% ± 12% | |
GABAergic neuron | 3 studies | 21% ± 2% | |
glutamatergic neuron | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of LAMA5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 28176.48 | 1445 / 1445 | 100% | 109.11 | 183 / 183 |
thymus | 100% | 25540.18 | 653 / 653 | 99% | 67.47 | 597 / 605 |
kidney | 100% | 26700.08 | 89 / 89 | 98% | 58.21 | 884 / 901 |
uterus | 100% | 26468.21 | 170 / 170 | 97% | 68.73 | 445 / 459 |
prostate | 100% | 32777.33 | 245 / 245 | 96% | 34.63 | 483 / 502 |
lung | 100% | 36574.78 | 577 / 578 | 94% | 60.81 | 1085 / 1155 |
breast | 100% | 23314.94 | 458 / 459 | 92% | 38.30 | 1032 / 1118 |
bladder | 100% | 26385.33 | 21 / 21 | 89% | 54.83 | 451 / 504 |
stomach | 94% | 17853.90 | 338 / 359 | 84% | 45.85 | 241 / 286 |
pancreas | 81% | 6402.88 | 265 / 328 | 93% | 50.66 | 166 / 178 |
intestine | 96% | 35009.16 | 931 / 966 | 77% | 32.48 | 408 / 527 |
ovary | 60% | 6321.57 | 108 / 180 | 99% | 132.82 | 427 / 430 |
adrenal gland | 97% | 9956.41 | 251 / 258 | 53% | 13.74 | 121 / 230 |
skin | 73% | 17662.30 | 1321 / 1809 | 57% | 17.50 | 270 / 472 |
liver | 76% | 5544.09 | 172 / 226 | 46% | 18.69 | 188 / 406 |
brain | 47% | 7612.91 | 1233 / 2642 | 75% | 18.15 | 527 / 705 |
blood vessel | 100% | 39539.56 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 12852.36 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.45 | 1 / 1 |
adipose | 100% | 22073.50 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 12207.48 | 849 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 60.24 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 96% | 51.19 | 77 / 80 |
muscle | 54% | 3682.39 | 435 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 1.10 | 2 / 29 |
peripheral blood | 0% | 6.78 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0060271 | Biological process | cilium assembly |
GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
GO_0099173 | Biological process | postsynapse organization |
GO_0030324 | Biological process | lung development |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0045995 | Biological process | regulation of embryonic development |
GO_0060445 | Biological process | branching involved in salivary gland morphogenesis |
GO_0016331 | Biological process | morphogenesis of embryonic epithelium |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0050678 | Biological process | regulation of epithelial cell proliferation |
GO_0030334 | Biological process | regulation of cell migration |
GO_0036484 | Biological process | trunk neural crest cell migration |
GO_0007517 | Biological process | muscle organ development |
GO_0001942 | Biological process | hair follicle development |
GO_0001738 | Biological process | morphogenesis of a polarized epithelium |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0016477 | Biological process | cell migration |
GO_0048705 | Biological process | skeletal system morphogenesis |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0070062 | Cellular component | extracellular exosome |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0098965 | Cellular component | extracellular matrix of synaptic cleft |
GO_0043259 | Cellular component | laminin-10 complex |
GO_0043260 | Cellular component | laminin-11 complex |
GO_0043083 | Cellular component | synaptic cleft |
GO_0005604 | Cellular component | basement membrane |
GO_0005610 | Cellular component | laminin-5 complex |
GO_0005634 | Cellular component | nucleus |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0005178 | Molecular function | integrin binding |
Gene name | LAMA5 |
Protein name | Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha) Alternative protein LAMA5 Laminin subunit alpha 5 |
Synonyms | KIAA1907 KIAA0533 |
Description | FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Plays a role in the regulation of skeletogenesis, through a mechanism that involves integrin-mediated signaling and PTK2B/PYK2 . . |
Accessions | L8EAG2 O15230 ENST00000474128.1 ENST00000497053.2 H7C5J6 ENST00000252999.7 [O15230-1] A0A087WYH7 |